Member Info for Kettle

I think Xyosted not getting approval surprised antares and they are not inexperienced, so it just happens. Although concentrating on renal the blood tests will show liver so no work there. There is a good chance Mtb will start acting like a proper share especially the interest this has caused. Roll on Monday!

Just read up on Antares pharma and their Xyosted, which got a crl from the fda, out of the blue. If interested On SmithOnStocks. It made me fell better except time it took.

Spike and Jimzi. It’s not you it’s me. Get a room !

With the facts you have either 1. Bury your head in sand
2. Sell and move on
3. Buy to dilute your loss to 20
Too much blame,venting etc. Your not an Mp deciding Brexit, get on with it with the vast experience and knowledge you have. Any rudeness is welcomed, rather me than rubbishing shares.

My wife who did not let me top up before approval is now happy I top up to dilute loss, and like all wives she’s always right so get topping up.

Just topped up again . OMG

Just bought 7000 shares at13 if that reflects anywhere

They will still have the data results from blood etc, so they just need to look it up. They would have liver kidney function results.

Chin up everyone, all data, blood tests etc is available. Until we hear what the query is and at this stage that’s all we know keep the faith. I thought I had lost a lot until I heard of some of the possible losses here so good luck to you all. Let’s have a Ramp now got nothing to lose.

With the data held they must be able to answer fda question right a way, it would all have been done. So an answer either way should be reasonably quick. I hope !

Pack it in you lot,it’s like a game of ping pong on the radio. Goodnight all and the best of luck. Just putting milk and cookies out.

That’s what I said,but shorter. A lot!

As I understood it Spike, they used a larger amount of test cases to bring percentage of deaths down to pass fda. So it will pass and all is good.

Petch can tell us the difference between blow and suck, i am sure.

It’s no wonder the price is low, there is jittery talk here and people admitting to being nervous and we are all quite positive imagine how a new investor sees this. I would wait until approval too. It’s gonna blow.

Not at all, you can now see it is not the stock he is upset with it is Mr Lumsden. His constant referral to messiah and us as disciples means we now know it is personal.

With appendage still in hand apparently!

Then he must have listened to your Amp forum pearls of wisdom and invest in Mtb and not Amp. You are confusing me now you tell Amp to buy into Mtb and Mtb, it’s too risky. What about Amarin.?

Well there you go then the odds of Mtb not getting approval simples

Being greedy I know, but positive!